Xenotransplantation: regulatory challenges-Reference-Cited by-同舟云学术

Xenotransplantation: regulatory challenges

Published:2001-06 Issue:3 Volume:12 Page:312-316
ISSN:0958-1669
Container-title:Current Opinion in Biotechnology
language:en
Short-container-title:Current Opinion in Biotechnology

Author:

Bloom Eda T

Publisher

Elsevier BV

Subject

Biomedical Engineering,Bioengineering,Biotechnology

Reference32 articles.

1. 1997 Report of the OPTN: Waiting List Activity and Donor Procurement. Richmond VA: UNOS; Rockville, Maryland: Division of Transplantation, Office of Special Programs, Health Resources and Services Administration, US Department of Health and Human Services, 1997.

2. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results;Fink;Cell Transplant,2000

3. Treatment of severe liver failure with a bioartificial liver;Chen;Ann New York Acad Sci,1997

4. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system;Wang;Cell Transplant,1998

5. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system;Pitkin;Artif Organs,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory Considerations and Oversight: A European Perspective;Xenotransplantation;2023

2. Evolution of Xenotransplantation as an Alternative to Shortage of Donors in Heart Transplantation;Cureus;2022-06-24

3. Corneal xenotransplantation: Where are we standing?;Progress in Retinal and Eye Research;2021-01

4. Current Perspective and Advancements of Alginate-Based Transplantation Technologies;Alginates - Recent Uses of This Natural Polymer;2020-02-05

5. Regulatory aspects of clinical xenotransplantation;International Journal of Surgery;2015-11